However, as with other forms of CKD, well-characterized in vivo model systems are needed to understand both the individual effects of APOL1 relevant to disease, and also the potential interaction of APOL1 with MYH9 in the context of anemic stress as observed in SCD. This evidence concerns the gene MYH9 and chronic kidney disease.